CC
IRWD icon

Cannell & Co’s Ironwood Pharmaceuticals IRWD Stock Holding History

Cannell & Co’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-18,770
Closed -$190K – 277
2015
Q2 		$190K Sell
18,770
-1,194
-6% -$13.9K 0.01% 259
2015
Q1 		$268K Sell
19,964
-727
-4% -$9.54K 0.01% 236
2014
Q4 		$265K Hold
20,691
– – 0.01% 242
2014
Q3 		$224K Sell
20,691
-3,582
-15% -$41K 0.01% 252
2014
Q2 		$312K Hold
24,273
– – 0.01% 235
2014
Q1 		$250K Buy
+24,273
New +$273K 0.01% 247

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMC
Rubric Capital Management (Connecticut) Stamford, Connecticut $6.44M AUM 43.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Cannell & Co's IRWD Position: Q3 2015 in Review

Cannell & Co sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2015, closing a stake of 18,770 shares — an estimated $190K sold.

Cannell & Co first reported a position in IRWD in Q1 2014 and held it in 6 quarters. The position peaked at $312K in Q2 2014. 130 funds tracked by Wall St. Rank hold IRWD as of Q3 2015.

  • Cannell & Co reported no remaining Ironwood Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Cannell & Co sold 18,770 Ironwood Pharmaceuticals shares in Q3 2015, an estimated $190K.
  • Cannell & Co first reported a position in Ironwood Pharmaceuticals in Q1 2014 and held it in 6 quarters.
  • Cannell & Co's Ironwood Pharmaceuticals position peaked at $312K in Q2 2014.
  • 130 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2015.

Based on Cannell & Co's 13F filing for Q3 2015, filed 13 Nov 2015.